Kongnakorn, T., Eckmann, C., Bassetti, M., Tichy, E., Di Virgilio, R., Baillon-Plot, N., & Charbonneau, C. (2019). Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI). Antimicrob Resist Infect Control.
Chicago ZitierstilKongnakorn, Thitima, Christian Eckmann, Matteo Bassetti, Eszter Tichy, Roberto Di Virgilio, Nathalie Baillon-Plot, und Claudie Charbonneau. "Cost-effectiveness Analysis Comparing Ceftazidime/avibactam (CAZ-AVI) As Empirical Treatment Comparing to Ceftolozane/tazobactam and to Meropenem for Complicated Intra-abdominal Infection (cIAI)." Antimicrob Resist Infect Control 2019.
MLA ZitierstilKongnakorn, Thitima, et al. "Cost-effectiveness Analysis Comparing Ceftazidime/avibactam (CAZ-AVI) As Empirical Treatment Comparing to Ceftolozane/tazobactam and to Meropenem for Complicated Intra-abdominal Infection (cIAI)." Antimicrob Resist Infect Control 2019.